 | • レポートコード：QY20ST-07172 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の抗エイズ薬市場について種類別（処方薬、非処方薬）、用途別（薬局、病院）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・抗エイズ薬市場の概要 ・世界の主要地域別抗エイズ薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の抗エイズ薬市場規模2015-2026：種類別（処方薬、非処方薬） ・世界の抗エイズ薬市場規模2015-2026：用途別（薬局、病院） ・抗エイズ薬の北米市場規模2015-2020 ・抗エイズ薬のヨーロッパ市場規模2015-2020 ・抗エイズ薬の中国市場規模2015-2020 ・抗エイズ薬の日本市場規模2015-2020 ・抗エイズ薬の東南アジア市場規模2015-2020 ・抗エイズ薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・抗エイズ薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗エイズ薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Anti-AIDs Drug Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Anti-AIDs Drug market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Anti-AIDs Drug market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Anti-AIDs Drug industry.
Based on our recent survey, we have several different scenarios about the Anti-AIDs Drug YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Anti-AIDs Drug will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Anti-AIDs Drug market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Anti-AIDs Drug market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Anti-AIDs Drug market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Anti-AIDs Drug market. The report also includes nautical information, where it shows Anti-AIDs Drug market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Anti-AIDs Drug market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Anti-AIDs Drug market.
Geographical Analysis:
Based on region, the global Anti-AIDs Drug market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Anti-AIDs Drug market are
GSK
Cipla
MSD
Gilead Sciences
Frontier Biotechnologies
…
Segment by Type
Prescription Drugs
Non-prescription Drugs
Segment by Application
Pharmacy
Hospital
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Anti-AIDs Drug market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Anti-AIDs Drug market.
• The market share of the global Anti-AIDs Drug market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Anti-AIDs Drug market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Anti-AIDs Drug market.
1 Anti-AIDs Drug Market Overview
1.1 Anti-AIDs Drug Product Scope
1.2 Anti-AIDs Drug Segment by Type
1.2.1 Global Anti-AIDs Drug Sales by Type (2020-2026)
1.2.2 Prescription Drugs
1.2.3 Non-prescription Drugs
1.3 Anti-AIDs Drug Segment by Application
1.3.1 Global Anti-AIDs Drug Sales Comparison by Application (2020-2026)
1.3.2 Pharmacy
1.3.3 Hospital
1.4 Anti-AIDs Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Anti-AIDs Drug Sales Growth Rate (2015-2026)
1.4.2 Global Anti-AIDs Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Anti-AIDs Drug Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Anti-AIDs Drug Industry Impact
1.5.1 How the Covid-19 is Affecting the Anti-AIDs Drug Industry
1.5.1.1 Anti-AIDs Drug Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Anti-AIDs Drug Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Anti-AIDs Drug Players to Combat Covid-19 Impact
2 Anti-AIDs Drug Estimate and Forecast by Region
2.1 Global Anti-AIDs Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Anti-AIDs Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Anti-AIDs Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Anti-AIDs Drug Revenue Market Share by Region (2015-2020)
2.3 Global Anti-AIDs Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Anti-AIDs Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Anti-AIDs Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Anti-AIDs Drug Estimates and Projections (2015-2026)
2.4.2 Europe Anti-AIDs Drug Estimates and Projections (2015-2026)
2.4.3 China Anti-AIDs Drug Estimates and Projections (2015-2026)
2.4.4 Japan Anti-AIDs Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Anti-AIDs Drug Estimates and Projections (2015-2026)
2.4.6 India Anti-AIDs Drug Estimates and Projections (2015-2026)
3 Global Anti-AIDs Drug Competition Landscape by Players
3.1 Global Top Anti-AIDs Drug Players by Sales (2015-2020)
3.2 Global Top Anti-AIDs Drug Players by Revenue (2015-2020)
3.3 Global Anti-AIDs Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-AIDs Drug as of 2019)
3.4 Global Anti-AIDs Drug Average Price by Company (2015-2020)
3.5 Manufacturers Anti-AIDs Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Anti-AIDs Drug Players (Opinion Leaders)
4 Global Anti-AIDs Drug Market Size by Type
4.1 Global Anti-AIDs Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Anti-AIDs Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Anti-AIDs Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Anti-AIDs Drug Price by Type (2014-2020)
4.2 Global Anti-AIDs Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Anti-AIDs Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-AIDs Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Anti-AIDs Drug Price Forecast by Type (2021-2026)
5 Global Anti-AIDs Drug Market Size by Application
5.1 Global Anti-AIDs Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Anti-AIDs Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Anti-AIDs Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Anti-AIDs Drug Price by Application (2015-2020)
5.2 Global Anti-AIDs Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Anti-AIDs Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-AIDs Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-AIDs Drug Price Forecast by Application (2021-2026)
3 North America Anti-AIDs Drug Market Facts & Figures
3.2 North America Anti-AIDs Drug Sales Market Share by Company (2015-2020)
3.3 North America Anti-AIDs Drug Sales Market Share by Type (2015-2020)
3.4 North America Anti-AIDs Drug Sales Market Share by Application (2015-2020)
4 Europe Anti-AIDs Drug Market Facts & Figures
4.2 Europe Anti-AIDs Drug Sales Market Share by Company (2015-2020)
4.3 Europe Anti-AIDs Drug Sales Market Share by Type (2015-2020)
4.4 Europe Anti-AIDs Drug Sales Market Share by Application (2015-2020)
5 China Anti-AIDs Drug Market Facts & Figures
5.2 China Anti-AIDs Drug Sales Market Share by Company (2015-2020)
5.3 China Anti-AIDs Drug Sales Market Share by Type (2015-2020)
5.4 China Anti-AIDs Drug Sales Market Share by Application (2015-2020)
6 Japan Anti-AIDs Drug Market Facts & Figures
6.2 Japan Anti-AIDs Drug Sales Market Share by Company (2015-2020)
6.3 Japan Anti-AIDs Drug Sales Market Share by Type (2015-2020)
6.4 Japan Anti-AIDs Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Anti-AIDs Drug Market Facts & Figures
7.2 Southeast Asia Anti-AIDs Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Anti-AIDs Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Anti-AIDs Drug Sales Market Share by Application (2015-2020)
8 India Anti-AIDs Drug Market Facts & Figures
8.2 India Anti-AIDs Drug Sales Market Share by Company (2015-2020)
8.3 India Anti-AIDs Drug Sales Market Share by Type (2015-2020)
8.4 India Anti-AIDs Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Anti-AIDs Drug Business
12.1 GSK
12.1.1 GSK Anti-AIDs Drug Corporation Information
12.1.2 GSK Anti-AIDs Drug Business Overview and Total Revenue
12.1.3 GSK Anti-AIDs Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GSK Anti-AIDs Drug Products Offered
12.1.5 GSK Recent Development
12.2 Cipla
12.2.1 Cipla Anti-AIDs Drug Corporation Information
12.2.2 Cipla Anti-AIDs Drug Business Overview and Total Revenue
12.2.3 Cipla Anti-AIDs Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Cipla Anti-AIDs Drug Products Offered
12.2.5 Cipla Recent Development
12.3 MSD
12.3.1 MSD Anti-AIDs Drug Corporation Information
12.3.2 MSD Anti-AIDs Drug Business Overview and Total Revenue
12.3.3 MSD Anti-AIDs Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 MSD Anti-AIDs Drug Products Offered
12.3.5 MSD Recent Development
12.4 Gilead Sciences
12.4.1 Gilead Sciences Anti-AIDs Drug Corporation Information
12.4.2 Gilead Sciences Anti-AIDs Drug Business Overview and Total Revenue
12.4.3 Gilead Sciences Anti-AIDs Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Gilead Sciences Anti-AIDs Drug Products Offered
12.4.5 Gilead Sciences Recent Development
12.5 Frontier Biotechnologies
12.5.1 Frontier Biotechnologies Anti-AIDs Drug Corporation Information
12.5.2 Frontier Biotechnologies Anti-AIDs Drug Business Overview and Total Revenue
12.5.3 Frontier Biotechnologies Anti-AIDs Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Frontier Biotechnologies Anti-AIDs Drug Products Offered
12.5.5 Frontier Biotechnologies Recent Development
…
13 Anti-AIDs Drug Manufacturing Cost Analysis
13.1 Anti-AIDs Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Anti-AIDs Drug
13.4 Anti-AIDs Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Anti-AIDs Drug Distributors List
14.3 Anti-AIDs Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Anti-AIDs Drug Sales (K Doses) Growth Rate by Type (2020-2026)
Table 2. Global Anti-AIDs Drug Sales (K Doses) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Anti-AIDs Drug Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Anti-AIDs Drug Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Anti-AIDs Drug Players to Combat Covid-19 Impact
Table 8. Global Market Anti-AIDs Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Anti-AIDs Drug Sales (K Doses) by Region (2015-2020)
Table 10. Global Anti-AIDs Drug Sales Market Share by Region (2015-2020)
Table 11. Global Anti-AIDs Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Anti-AIDs Drug Revenue Share by Region (2015-2020)
Table 13. Global Anti-AIDs Drug Sales (K Doses) Forecast by Region (2021-2026)
Table 14. Global Anti-AIDs Drug Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Anti-AIDs Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Anti-AIDs Drug Revenue Share Forecast by Region (2021-2026)
Table 17. Global Anti-AIDs Drug (K Doses) of Key Companies (2015-2020)
Table 18. Global Anti-AIDs Drug Sales Share by Company (2015-2020)
Table 19. Global Anti-AIDs Drug Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Anti-AIDs Drug Revenue Share by Company (2015-2020)
Table 21. Global Anti-AIDs Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-AIDs Drug as of 2019)
Table 22. Global Anti-AIDs Drug Average Price (USD/Dose) of Key Company (2015-2020)
Table 23. Manufacturers Anti-AIDs Drug Manufacturing Sites and Area Served
Table 24. Manufacturers Anti-AIDs Drug Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Anti-AIDs Drug Players
Table 27. Global Anti-AIDs Drug Sales (K Doses) by Type (2015-2020)
Table 28. Global Anti-AIDs Drug Sales Share by Type (2015-2020)
Table 29. Global Anti-AIDs Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Anti-AIDs Drug Price (K Doses) by Type (2015-2020)
Table 31. Global Anti-AIDs Drug Sales Share by Type (2021-2026)
Table 32. Global Anti-AIDs Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Anti-AIDs Drug Revenue Share by Type (2021-2026)
Table 34. Global Anti-AIDs Drug Price (K Doses) by Type (2021-2026)
Table 35. Global Anti-AIDs Drug Sales (K Doses) by Application (2015-2020)
Table 36. Global Anti-AIDs Drug Sales Share by Application (2015-2020)
Table 37. Global Anti-AIDs Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Anti-AIDs Drug Price (K Doses) by Application (2015-2020)
Table 39. Global Anti-AIDs Drug Sales (K Doses) by Application (2021-2026)
Table 40. Global Anti-AIDs Drug Sales Share by Application (2021-2026)
Table 41. Global Anti-AIDs Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Anti-AIDs Drug Revenue Share by Application (2021-2026)
Table 43. Global Anti-AIDs Drug Price (K Doses) by Application (2021-2026)
Table 44. United States Anti-AIDs Drug Sales (K Doses) by Company (2015-2020)
Table 45. United States Anti-AIDs Drug Sales Market Share by Company (2015-2020)
Table 46. United States Anti-AIDs Drug Sales (K Doses) by Type (2015-2020)
Table 47. United States Anti-AIDs Drug Sales Market Share by Type (2015-2020)
Table 48. United States Anti-AIDs Drug Sales (K Doses) by Application (2015-2020)
Table 49. United States Anti-AIDs Drug Sales Market Share by Application (2015-2020)
Table 50. Europe Anti-AIDs Drug Sales (K Doses) by Company (2015-2020)
Table 51. Europe Anti-AIDs Drug Sales Market Share by Company (2015-2020)
Table 52. Europe Anti-AIDs Drug Sales (K Doses) by Type (2015-2020)
Table 53. Europe Anti-AIDs Drug Sales Market Share by Type (2015-2020)
Table 54. Europe Anti-AIDs Drug Sales (K Doses) by Application (2015-2020)
Table 55. Europe Anti-AIDs Drug Sales Market Share by Type (2015-2020)
Table 56. China Anti-AIDs Drug Sales (K Doses) by Company (2015-2020)
Table 57. China Anti-AIDs Drug Sales Market Share by Company (2015-2020)
Table 58. China Anti-AIDs Drug Sales (K Doses) by Type (2015-2020)
Table 59. China Anti-AIDs Drug Sales Market Share by Type (2015-2020)
Table 60. China Anti-AIDs Drug Sales (K Doses) by Application (2015-2020)
Table 61. China Anti-AIDs Drug Sales Market Share by Application (2015-2020)
Table 62. Japan Anti-AIDs Drug Sales (K Doses) by Company (2015-2020)
Table 63. Japan Anti-AIDs Drug Sales Market Share by Company (2015-2020)
Table 64. Japan Anti-AIDs Drug Sales (K Doses) by Type (2015-2020)
Table 65. Japan Anti-AIDs Drug Sales Market Share by Type (2015-2020)
Table 66. Japan Anti-AIDs Drug Sales (K Doses) by Application (2015-2020)
Table 67. Japan Anti-AIDs Drug Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Anti-AIDs Drug Sales (K Doses) by Company (2015-2020)
Table 69. Southeast Asia Anti-AIDs Drug Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Anti-AIDs Drug Sales (K Doses) by Type (2015-2020)
Table 71. Southeast Asia Anti-AIDs Drug Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Anti-AIDs Drug Sales (K Doses) by Type (2015-2020)
Table 73. Southeast Asia Anti-AIDs Drug Sales Market Share by Application (2015-2020)
Table 74. India Anti-AIDs Drug Sales (K Doses) by Company (2015-2020)
Table 75. India Anti-AIDs Drug Sales Market Share by Company (2015-2020)
Table 76. India Anti-AIDs Drug Sales (K Doses) by Type (2015-2020)
Table 77. India Anti-AIDs Drug Sales Market Share by Type (2015-2020)
Table 78. India Anti-AIDs Drug Sales (K Doses) by Application (2015-2020)
Table 79. India Anti-AIDs Drug Sales Market Share by Application (2015-2020)
Table 80. GSK Corporation Information
Table 81. GSK Description and Business Overview
Table 82. GSK Anti-AIDs Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. GSK Anti-AIDs Drug Product
Table 84. GSK Recent Development
Table 85. Cipla Corporation Information
Table 86. Cipla Description and Business Overview
Table 87. Cipla Anti-AIDs Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. Cipla Anti-AIDs Drug Product
Table 89. Cipla Recent Development
Table 90. MSD Corporation Information
Table 91. MSD Description and Business Overview
Table 92. MSD Anti-AIDs Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. MSD Anti-AIDs Drug Product
Table 94. MSD Recent Development
Table 95. Gilead Sciences Corporation Information
Table 96. Gilead Sciences Description and Business Overview
Table 97. Gilead Sciences Anti-AIDs Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Gilead Sciences Anti-AIDs Drug Product
Table 99. Gilead Sciences Recent Development
Table . Frontier Biotechnologies Corporation Information
Table . Frontier Biotechnologies Description and Business Overview
Table . Frontier Biotechnologies Anti-AIDs Drug Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2015-2020)
Table . Frontier Biotechnologies Anti-AIDs Drug Product
Table . Frontier Biotechnologies Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Anti-AIDs Drug Distributors List
Table 108. Anti-AIDs Drug Customers List
Table 109. Market Key Trends
Table 110. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 111. Key Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-AIDs Drug Product Picture
Figure 2. Global Anti-AIDs Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Anti-AIDs Drug Market Share by Application in 2020 & 2026
Figure 6. Pharmacy Examples
Figure 7. Hospital Examples
Figure 8. Global Anti-AIDs Drug Sales (K Doses) Growth Rate (2015-2026)
Figure 9. Global Anti-AIDs Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Anti-AIDs Drug Price Trends Growth Rate (2015-2026) (USD/Dose)
Figure 11. Global Anti-AIDs Drug Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Anti-AIDs Drug Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Anti-AIDs Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Anti-AIDs Drug Sales (K Doses) Growth Rate (2015-2026)
Figure 15. Europe Anti-AIDs Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Anti-AIDs Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Anti-AIDs Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Anti-AIDs Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Anti-AIDs Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Anti-AIDs Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Anti-AIDs Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Anti-AIDs Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Anti-AIDs Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Anti-AIDs Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Anti-AIDs Drug Players Market Share by Revenue in Anti-AIDs Drug 2015 & 2019
Figure 26. Anti-AIDs Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Anti-AIDs Drug Revenue Share by Type (2015-2020)
Figure 28. Global Anti-AIDs Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Anti-AIDs Drug Revenue Share by Application (2015-2020)
Figure 30. Global Anti-AIDs Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Anti-AIDs Drug Sales Market Share by Type in 2019
Figure 32. United States Anti-AIDs Drug Sales Market Share by Type in 2019
Figure 33. Europe Anti-AIDs Drug Sales Market Share by Company in 2019
Figure 34. Europe Anti-AIDs Drug Sales Market Share by Type in 2019
Figure 35. Europe Anti-AIDs Drug Sales Market Share by Application in 2019
Figure 36. China Anti-AIDs Drug Sales Market Share by Company in 2019
Figure 37. China Anti-AIDs Drug Sales Market Share by Type in 2019
Figure 38. China Anti-AIDs Drug Sales Market Share by Application in 2019
Figure 39. Japan Anti-AIDs Drug Sales Market Share by Company in 2019
Figure 40. Japan Anti-AIDs Drug Sales Market Share by Type in 2019
Figure 41. Japan Anti-AIDs Drug Sales Market Share by Application in 2019
Figure 42. Southeast Asia Anti-AIDs Drug Sales Market Share by Company in 2019
Figure 43. Southeast Asia Anti-AIDs Drug Sales Market Share by Type in 2019
Figure 44. Southeast Asia Anti-AIDs Drug Sales Market Share by Application in 2019
Figure 45. India Anti-AIDs Drug Sales Market Share by Company in 2019
Figure 46. India Anti-AIDs Drug Sales Market Share by Type in 2019
Figure 47. India Anti-AIDs Drug Sales Market Share by Application in 2019
Figure 48. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. MSD Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Frontier Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Key Raw Materials Price Trend
Figure 54. Manufacturing Cost Structure of Anti-AIDs Drug
Figure 55. Manufacturing Process Analysis of Anti-AIDs Drug
Figure 56. Anti-AIDs Drug Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Porter's Five Forces Analysis
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
緑内障治療薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Anti-glaucoma Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-glaucoma Drug market …- 抗腫瘍薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anti-tumor Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- ボックス補聴器の世界市場レポート2020 Market Analysis and Insights: Global Box Hearing Aids Market Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 20…
- 自動安全装置の世界市場レポート2020 Auto safety aids limit or prevent certain hazards of the machine through its own structural functions, or limit the risk factors such as speed of movement and pressure. Market Analysis and Insights: Global Auto Safety Aids Market Since the COVID-19 virus outbreak in December 2019, the disease has sp…
- 自動安全装置の世界市場レポート2020 Auto safety aids limit or prevent certain hazards of the machine through its own structural functions, or limit the risk factors such as speed of movement and pressure. Market Analysis and Insights: Global Auto Safety Aids Market Since the COVID-19 virus outbreak in December 2019, the disease has sp…